These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Role of domain 3 of calmodulin in activation of calmodulin-stimulated phosphodiesterase and smooth muscle myosin light chain kinase. Su Z; Fan D; George SE J Biol Chem; 1994 Jun; 269(24):16761-5. PubMed ID: 8206999 [TBL] [Abstract][Full Text] [Related]
28. Regulation of mouse oocyte maturation: involvement of cyclic AMP phosphodiesterase and calmodulin. Bornslaeger EA; Wilde MW; Schultz RM Dev Biol; 1984 Oct; 105(2):488-99. PubMed ID: 6207062 [TBL] [Abstract][Full Text] [Related]
29. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions. LeBon TR; Kasuya J; Paxton RJ; Belfrage P; Hockman S; Manganiello VC; Fujita Yamaguchi Y Endocrinology; 1992 Jun; 130(6):3265-74. PubMed ID: 1317779 [TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3',5'-cyclic nucleotide phosphodiesterases. Loughney K; Martins TJ; Harris EA; Sadhu K; Hicks JB; Sonnenburg WK; Beavo JA; Ferguson K J Biol Chem; 1996 Jan; 271(2):796-806. PubMed ID: 8557689 [TBL] [Abstract][Full Text] [Related]
31. Purification and partial characterization of membrane-associated type II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain. Whalin ME; Strada SJ; Thompson WJ Biochim Biophys Acta; 1988 Oct; 972(1):79-94. PubMed ID: 2846074 [TBL] [Abstract][Full Text] [Related]
32. Interaction of ganglioside with specific peptide sequences as a mechanism for the modulation of calmodulin-dependent enzymes. Higashi H; Yoshida S; Sato K; Yamagata T J Biochem; 1996 Jul; 120(1):66-73. PubMed ID: 8864846 [TBL] [Abstract][Full Text] [Related]
33. Calmodulin-like activity and calcium-dependent phosphodiesterase in purified cells of the rat zona glomerulosa and zona fasciculata. Koletsky RJ; Brown EM; Williams GH Endocrinology; 1983 Aug; 113(2):485-90. PubMed ID: 6307640 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists. Sharma RK; Wang JH; Wu Z J Neurochem; 1997 Aug; 69(2):845-50. PubMed ID: 9231746 [TBL] [Abstract][Full Text] [Related]
35. Purification of calmodulin-stimulated cyclic nucleotide phosphodiesterase by monoclonal antibody affinity chromatography. Hansen RS; Charbonneau H; Beavo JA Methods Enzymol; 1988; 159():543-57. PubMed ID: 2842618 [TBL] [Abstract][Full Text] [Related]
36. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase. Itoh H; Hidaka H J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352 [TBL] [Abstract][Full Text] [Related]
37. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel. Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380 [TBL] [Abstract][Full Text] [Related]
38. Detailed characterization of a purified type 4 phosphodiesterase, HSPDE4B2B: differentiation of high- and low-affinity (R)-rolipram binding. Rocque WJ; Holmes WD; Patel IR; Dougherty RW; Ittoop O; Overton L; Hoffman CR; Wisely GB; Willard DH; Luther MA Protein Expr Purif; 1997 Mar; 9(2):191-202. PubMed ID: 9056484 [TBL] [Abstract][Full Text] [Related]